(Q38018539)

27 August 2017

title

Immunological orchestration of liver fibrosis (English)

1 reference

27 August 2017

1 reference

4

M Eric Gershwin

1 reference

27 August 2017

Hajime Tanaka

1

1 reference

27 August 2017

Patrick S C Leung

series ordinal

2

1 reference

27 August 2017

Tom P Kenny

series ordinal

3

1 reference

27 August 2017

Christopher L Bowlus

series ordinal

5

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Clinical Reviews in Allergy & Immunology

27 August 2017

published in

1 reference

27 August 2017

volume

43

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

220-229

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-012-8323-1

27 August 2017

exact match

0 references

cites work

Searching for miR-acles in cardiac fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Renal fibrosis: new insights into the pathogenesis and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Targeted treatments for cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Liver fibrosis: from the bench to clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Mechanisms of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Alternative activation of macrophages: mechanism and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Cellular and molecular mechanisms of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

The interleukin-17 pathway is involved in human alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Hepatic lipocytes: the principal collagen-producing cells of normal rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Changes in melatonin concentrations during IFN therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Hepatic stellate cell behavior during resolution of liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Hepatic blood flow regulation by stellate cells in normal and injured liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Cellular pathophysiology of portal hypertension and prospects for management with gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Pathogenesis of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Transforming growth factor beta and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Gamma-interferon inhibits collagen synthesis in vivo in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Hepatic IL-17 responses in human and murine primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Biology of interleukin-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

IL-22: a critical mediator in mucosal host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Critical contribution of liver natural killer T cells to a murine model of hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Role of Vα 14 NKT cells in the development of impaired liver regeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Senescence of activated stellate cells limits liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

A recent perspective on alcohol, immunity, and host defense.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Silencing a killer among us: ethanol impairs immune surveillance of activated stellate cells by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Toll-like receptor signaling in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Toll-like Receptor 4 and Hepatic Fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Liver: An organ with predominant innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Pattern recognition receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

A comparison of fibrosis progression in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

B cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

B cell depletion therapy exacerbates murine primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Liver autoimmunity triggered by microbial activation of natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Interleukin-35: odd one out or part of the family?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Biliary cirrhosis in a child with inherited interleukin-12 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Role of IL-17 and Th17 cells in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Accumulating CD57 + CD3 + natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Role of TLR9 in hepatic stellate cells and experimental liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8323-1

Activation-induced cell death of hepatic stellate cells by the innate immune system

21 January 2018

1 reference

12 December 2020

Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis

1 reference

12 December 2020

Deaths: final data for 2008.

1 reference

12 December 2020

Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta

1 reference

12 December 2020

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells

1 reference

12 December 2020

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

1 reference

12 December 2020

IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis

1 reference

12 December 2020

Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis

1 reference

12 December 2020

Isolation of a lipocyte-rich fraction from rat liver nonparenchymal cells

1 reference

12 December 2020

Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma

1 reference

12 December 2020

IL-17 expression is correlated with hepatitis B‑related liver diseases and fibrosis.

1 reference

12 December 2020

In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha

1 reference

12 December 2020

Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing

1 reference

12 December 2020

Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma

1 reference

12 December 2020

Granulomas in primary biliary cirrhosis: a prognostic feature

1 reference

12 December 2020

Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3.

1 reference

12 December 2020

Hepatic stellate cells and the regulation of liver inflammation

1 reference

12 December 2020

Primary biliary cirrhosis

1 reference

12 December 2020

Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis

1 reference

12 December 2020

Decrease in the prevalence of IL-4-producing CD4+ T cells in patients with advanced stage of primary biliary cirrhosis

1 reference

12 December 2020

IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver

1 reference

12 December 2020

Angiotensin II induces contraction and proliferation of human hepatic stellate cells

1 reference

12 December 2020

Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption

1 reference

12 December 2020

Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism

1 reference

12 December 2020

Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases

1 reference

12 December 2020

PDGF and signal transduction in hepatic stellate cells

1 reference

12 December 2020

Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis.

1 reference

12 December 2020

10.1007/S12016-012-8323-1

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1008382310

0 references

1 reference